Product Images Emend

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Emend NDC 0006-3941 by Merck Sharp & Dohme Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - emend iv 01

Chemical Structure - emend iv 01

PRINCIPAL DISPLAY PANEL - Carton 115 mg - emend iv 02

PRINCIPAL DISPLAY PANEL - Carton 115 mg - emend iv 02

PRINCIPAL DISPLAY PANEL - 150 mg Vial Carton - emend iv 03

PRINCIPAL DISPLAY PANEL - 150 mg Vial Carton - emend iv 03

Emend® (fosaprepitant dimeglumine) is a sterile lyophilized powder in a single-dose vial for intravenous use. It is only to be used after reconstitution and dilution and is stable for 24 hours at room temperature. The usual dosage is mentioned in the prescription information. The vial must be refrigerated at 2°C-8°C (36°F-46°F). The drug should not be used with solutions containing divalent cations, including lactated Ringer's solution and Hartmann's solution. Inactive ingredients include edetate disodium, polsorbate 80, anhydrous lactose, sodium hydroxide, and hydrochloric acid for pH adjustment. The manufacturer of Emend® is MerckSharp & Dohme, a subsidiary of Merck & Co., Inc. The active ingredient is formulated in the US and is from France.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.